Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,700 | 143 | 99.7% |
| Education | $7.67 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $513.02 | 20 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $270.36 | 17 | $0 (2024) |
| Lilly USA, LLC | $175.60 | 10 | $0 (2022) |
| Amgen Inc. | $168.12 | 9 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $167.76 | 5 | $0 (2021) |
| Novo Nordisk Inc | $157.98 | 11 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $154.66 | 11 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $144.53 | 10 | $0 (2022) |
| PFIZER INC. | $128.66 | 7 | $0 (2022) |
| Amarin Pharma Inc. | $123.68 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48.16 | 3 | AstraZeneca Pharmaceuticals LP ($48.16) |
| 2023 | $239.37 | 12 | Novo Nordisk Inc ($30.94) |
| 2022 | $613.15 | 36 | AstraZeneca Pharmaceuticals LP ($76.00) |
| 2021 | $1,807 | 93 | AbbVie Inc. ($425.53) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Respiratory | ||||||
| 05/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Respiratory | ||||||
| 11/30/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Inflammation | ||||||
| 11/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Oncology | ||||||
| 11/09/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes | ||||||
| 11/06/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/09/2023 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 09/26/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/24/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Inflammation | ||||||
| 08/17/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/14/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: UROLOGY | ||||||
| 08/11/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Diabetes Care | ||||||
| 08/07/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/25/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $14.48 | General |
| Category: Cardiovascular | ||||||
| 08/15/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Respiratory | ||||||
| 08/11/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 08/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/04/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: PRIMARY CARE | ||||||
| 08/03/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardiology | ||||||
| 07/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $13.53 | General |
| Category: Cardiovascular | ||||||
| 06/22/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,122 | 1,253 | $170,599 | $47,448 |
| 2022 | 7 | 425 | 452 | $68,506 | $22,182 |
| 2021 | 6 | 173 | 174 | $30,460 | $10,353 |
| 2020 | 4 | 88 | 88 | $18,500 | $3,283 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 497 | 531 | $99,722 | $26,924 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 111 | 111 | $26,073 | $5,355 | 20.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 95 | 99 | $10,012 | $3,427 | 34.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 85 | 173 | $5,726 | $2,774 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 40 | $10,579 | $2,767 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 23 | $8,519 | $2,372 | 27.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 35 | 36 | $5,159 | $1,926 | 37.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 21 | 21 | $694.26 | $324.00 | 46.7% |
| 90714 | Diphtheria and tetanus vaccine (7 years or older) | Office | 2023 | 14 | 14 | $805.06 | $296.64 | 36.8% |
| 90471 | Administration of vaccine | Office | 2023 | 15 | 15 | $616.70 | $192.08 | 31.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 20 | $342.80 | $168.00 | 49.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 15 | 15 | $316.80 | $155.25 | 49.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 18 | $561.00 | $154.56 | 27.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 66 | 68 | $331.50 | $149.60 | 45.1% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 18 | 18 | $290.52 | $142.38 | 49.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $453.60 | $130.91 | 28.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 17 | 17 | $264.18 | $125.28 | 47.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 19 | 19 | $132.24 | $64.79 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 214 | $41,736 | $13,152 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 66 | 66 | $15,809 | $4,941 | 31.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 48 | 48 | $4,740 | $2,030 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $3,388 | $1,092 | 32.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 22 | 44 | $1,592 | $715.64 | 45.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 14 | $467.12 | $133.25 | 28.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 52 | 53 | $774.00 | $117.18 | 15.1% |
About Greg Flinders, P.A
Greg Flinders, P.A is a Physician Assistant healthcare provider based in Cape Coral, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/12/2009. The National Provider Identifier (NPI) number assigned to this provider is 1386971240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Greg Flinders, P.A has received a total of $2,707 in payments from pharmaceutical and medical device companies, with $48.16 received in 2024. These payments were reported across 144 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,700).
As a Medicare-enrolled provider, Flinders has provided services to 1,808 Medicare beneficiaries, totaling 1,967 services with total Medicare billing of $83,265. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Cape Coral, FL
- Active Since 11/12/2009
- Last Updated 12/04/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1386971240
Products in Payments
- UBRELVY (Drug) $345.98
- NURTEC ODT (Drug) $222.49
- FARXIGA (Drug) $169.81
- Livalo (Drug) $154.66
- XARELTO (Drug) $144.53
- TRULICITY (Drug) $136.59
- Otezla (Drug) $131.05
- ELIQUIS (Drug) $128.66
- Vascepa (Drug) $123.68
- TRINTELLIX (Drug) $104.89
- Ozempic (Drug) $87.44
- TRELEGY ELLIPTA (Drug) $77.60
- QULIPTA (Drug) $77.20
- ADUHELM (Biological) $68.53
- VRAYLAR (Drug) $66.15
- XIFAXAN (Drug) $62.45
- BREZTRI (Drug) $52.39
- AIRSUPRA (Drug) $48.16
- RYBELSUS (Drug) $40.78
- ZENPEP (Drug) $30.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Cape Coral
Angela Vallejo, Pa-C, PA-C
Physician Assistant — Payments: $7,757
Mrs. Robin Silverman, P.a, P.A
Physician Assistant — Payments: $7,530
Bethany Edouard, Pa, PA
Physician Assistant — Payments: $6,864
Hannah Medina, Pa-C, PA-C
Physician Assistant — Payments: $6,396
Marilyn Bataille, Pa-C, PA-C
Physician Assistant — Payments: $5,735
Ms. Laura Perez, Pa-C, PA-C
Physician Assistant — Payments: $3,952